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Abstract
The potential of a metabolomics method to detect statistically significant perturbations in the
metabolome of an organism is enhanced by excellent analytical precision, unequivocal iden-
tification, and broad metabolomic coverage. While the former two metrics are usually asso-
ciated with targeted metabolomics and the latter with non-targeted metabolomics, a
systematic comparison of the performance of both approaches has not yet been carried out.
The present work reports on the development and performance evaluation of separate tar-
geted and non-targeted metabolomics methods. The targeted approach facilitated determi-
nation of 181 metabolites (quantitative analysis of 18 amino acids, 11 biogenic amines, 5
neurotransmitters, 5 nucleobases and semi-quantitative analysis of 50 carnitines, 83 phos-
phatidylcholines, and 9 sphingomyelins) using ultra-performance liquid chromatography-
tandem mass spectrometry (UPLC-MS/MS) and flow injection-tandem mass spectrometry
(FI-MS/MS). Method accuracy and/or precision were assessed using replicate samples of
NIST SRM1950 as well as fish liver and brain tissue from Gilthead Bream (Sparus aurata).
The non-target approach involved UPLC-high resolution (Orbitrap) mass spectrometry
(UPLC-HRMS). Testing of ionization mode and stationary phase revealed that a combina-
tion of positive electrospray ionization and HILIC chromatography produced the largest
number of chromatographic features during non-target analysis. Furthermore, an evaluation
of 4 different sequence drift correction algorithms, and combinations thereof, revealed that
batchCorr produced the best precision in almost every test. However, even following correc-
tion of non-target data for signal drift, the precision of targeted data was better, confirming
our existing assumptions about the strengths of targeted metabolomics. Finally, the accu-
racy of the online MS2-library mzCloud was evaluated using reference standards for 38 dif-
ferent metabolites. This is among the few studies that have systematically evaluated the
performance of targeted and non-targeted metabolomics and provides new insight into the
advantages and disadvantages of each approach.
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Introduction
Metabolomics has become an increasingly powerful research tool in the natural and life sci-
ences for elucidating biological perturbations in response to internal or external stimuli. Strat-
egies for performing metabolomics experiments are classified as either ‘targeted’ or ‘non-
targeted’. Targeted approaches involve multiplexed analysis of known metabolites and have
proven useful for assessing organismal response with respect to development[1,2] environ-
mental perturbation[1,3,4], xenobiotic exposure[5–7] or disease pathology and diagnosis in
the life sciences[8–10]. In comparison, non-targeted approaches seek to detect as many dis-
tinct features as possible in a single analysis and, combined with multivariate statistics, identify
biomarkers which distinguish case from control groups. There are a wide range of examples
where non-targeted metabolomics has been employed in both the natural and life sciences,
including assessment of complex interactions between diet and health[11,12], fingerprinting
sub-lethal responses to environmental contaminants[13,14] and novel biomarker discovery
associated with disease or xenobiotic exposure[15,16].
Among targeted approaches, native and isotopically-labelled standards facilitate metabolite
identification and quantification, thereby reducing false positives which may lead to misinter-
pretation of an affected biological pathway. Quantitative metabolomics may be used to estab-
lish baseline metabolite levels in a tissue or organism for inter-laboratory comparison or for
defining healthy versus ‘perturbed’ states. The use of isotopically labelled internal standards
(IS) can also help to account for matrix-induced ionization effects which affect analytical preci-
sion, thereby enhancing sensitivity of the assay for detecting a biological response[17]. The
major disadvantage of targeted approaches is limited coverage of the metabolome which
increases the risk of overlooking the metabolomic response of interest.
In contrast to targeted metabolomics, non-targeted approaches offer the potential to deter-
mine novel biomarkers. However, this approach is never truly unbiased, since researchers
must select a combination of stationary phase and ionization mode which may improve detec-
tion of some substances and reduce detection of others. The effect of these instrumental
parameters on analytical coverage are poorly reported in the literature. False identification of
metabolites or bias/signal drift introduced from matrix effects may also occur in non-targeted
metabolomics due to a lack of standards. The latter may be corrected using any number of dif-
ferent signal-drift correction algorithms, but the relative performance of these approaches
remains unclear. Finally, the lack of absolute quantification in non-targeted metabolomics
hampers benchmarking of ‘normal’ metabolite levels and ultimately interlaboratory compari-
son of results.
In theory, the weaknesses encountered in one metabolomics approach are the respective
strengths of the other. Nevertheless, there are few studies which have systematically compared
the performance of targeted and non-targeted metabolomics[18]. The present work aimed to
address this knowledge gap. Firstly, we developed independent targeted and non-targeted
metabolomics platforms: The targeted approach involved (i) ultra-high performance liquid
chromatography tandem mass spectrometry (UHPLC-MS/MS) for quantitative determination
of 39 metabolites; and (ii) flow injection-tandem mass spectrometry (FI-MS/MS) for semi-
quantitative analysis of 142 lipids. The non-targeted approaches were based on UHPLC-Orbi-
trap-mass spectrometry. Secondly, within the non-targeted approach, we assessed which com-
bination of ionization mode (positive or negative) and stationary phase (C18 versus HILIC)
produced the greatest analytical coverage (i.e. number of features). We then investigated the
effect of a wide range of signal drift correction algorithms on the precision of non-targeted
measurements as well as how well MS2 mass-library mzCloud performed in identifying com-
pounds in the different sample matrices. Finally, we compared the precision of the optimized
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targeted and non-targeted methods for a limited number of substances detected by both
approaches through analysis of replicate biological samples (including reference materials).
This is among the few studies that have systematically evaluated the performance of targeted
and non-targeted metabolomics and provides insight into the advantages and disadvantages of
each approach.
Materials and methods
Metabolite nomenclature
A full list of targets and abbreviations, including Human Metabolome Database (HMDB)
numbers, are provided in S1 Table. Briefly, for amino acids, neurotransmitters, and nucleo-
bases, we adopted a standard 3-letter notation (e.g. alanine = ala, leucine = leu, etc). Glycero-
phospholipids were defined based on the presence of ester and/or ether bonds (represented by
an ‘a’ or ‘e’, respectively), the length of fatty acid chains, and the number of double bonds. For
example, lysoPCaC20:2 represents a phosphatidylcholine containing 1 fatty acid of 20 carbons
in length, with 2 double bonds. Two letters (ae = acyl-alkyl, aa = diacyl) indicate fatty acids
bound to two glycerol positions (e.g. PCaaC20:2). Sphingomyelin (SM) nomenclature includes
a ‘d’ denoting the backbone sphingosine, with chain length and the number of double bonds
separated by a colon, and a ‘C’ denoting the fatty acid, again with chain length and the number
of double bonds separated by a colon (e.g. SM (d18:0/C18:1). Carnitines are denoted by a ‘C’
followed by the corresponding number of carbons and double bonds separated by a colon (e.g.
C2:0). Note that this naming system, and the associated FI-MS/MS methods used herein does
not identify the exact position of double bonds, nor the number of carbon atoms on different
fatty acid side chains.
Standards and reagents
Acetonitrile (ACN; HPLC grade) and chloroform (CHCl3) were acquired from VWR Chemi-
cals (Radnor, PA, USA). Methanol (MeOH; HPLC grade) was acquired from Merck (Darm-
stadt, Germany). Water was filtered in-house to a total organic content< 3 ppb using a Milli-
Q Integral 3 and a Millipak express 40 (0.22μm) filter (Millipore, Merck, Darmstadt, Ger-
many). Native standards for amino acids, biogenic amines, neurotransmitters, and TCA inter-
mediates were all of analytical grade and purchased from Sigma-Aldrich (St. Louis, Missouri,
United States). Native carnitine and phospholipid standards (C2:0, PCaaC34:0, PCaaC28:2,
lysoPCaC10:0, lysoPCaC24:0) were purchased from Avanti Polar Lipids (Alabaster, United
States). The IS SMC16:0, L-methionine-methyl (13C, D3) and C0 (trimethyl-D9) were all
acquired from Sigma-Aldrich (St. Louis, Missouri, United States). The remaining lipid ISs
(lysoPCaC13:0, lysoPCaC17:1, PCaaC25:0, PCaaC31:1, PCaaC43:6 and SMC12:0) were
acquired from Avanti Polar Lipids (Alabaster, United States). ZrO (2.0 mm) and stainless steel
beads (4.8 mm) were purchased from Next Advance (New York, United States).
Native amino acids, biogenic amines, nucleobases and neurotransmitters were prepared in
a mixture of filtered Milli-Q water and MeOH (60:40) containing 1% (v/v) formic acid (FA),
while carnitines and lipids were prepared in 100% MeOH. The IS used for amino acids, bio-
genic amines, nucleobases and neurotransmitters was solved in 20:80, MilliQ and MeOH with
1% (v/v) FA addition. The ISs for carnitines and lipids were solved in pure MeOH.
A stock solution of native amino acids, biogenic amines, nucleobases and neurotransmitters
was diluted into 11 calibration standards ranging from 346.3 pM to 161.2 μM of individual tar-
gets (S2 Table). Final IS concentration in samples and standards for the QqQHILIC analysis was
0.19 μM while the five standards used for QqQFI analysis ranged from 0.11 to 0.57 μM (S2
Table).
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Plasma and tissue samples
The fish processing was carried out in careful accordance to the rules of the Local Authority
and evaluated and approved by the Bioethics Committee of the University of the Basque Coun-
try (UPV/EHU) (CEEA/380/2014/ETXEBARRIA LOIZATE). Post termination and dissec-
tion, the brain and liver samples were stored at -80˚C, shipped on dry ice to Stockholm
University where they were once again stored at -80˚C prior to analysis. Standard Reference
Material (SRM) 1950, Metabolites in Human Plasma, was obtained from the National Institute
of Standards and Technology (NIST). Upon receipt, the material was aliquoted into 12 vials
(100 μL each), and then stored at -80˚C prior to use. The NIST material was extracted in two
batches together with gilthead bream brain or liver tissue, at two different time points: the first
and second batch containing four and eight replicates, respectively. Detailed sample informa-
tion is available in S3 Table.
Workflow
The workflow of this study is outlined in Fig 1. The first step involved analysis of three sample
types (NIST human plasma, fish liver and fish brain) using 3 different analytical approaches;
UPLC-HILIC-MS/MS (QqQHILIC), FI-MS/MS (QqQFI) and UPLC-Orbitrap MS (OrbiHILIC/
C18+/-). The QqQHILIC and QqQFI analyses (both targeted) consisted of acquisition followed by
quantitation or semi-quantitation with isotopic deconvolution, respectively. Accuracy was
assessed by comparing measured concentrations in NIST human plasma to reference concen-
trations while precision was assessed as the relative standard deviation (RSD) of replicate
plasma and tissue samples. Non-targeted analysis involved optimization of peak-picking set-
tings, after which 7 different signal drift correction methods were evaluated. The signal drift
correction method yielding the lowest RSD was used for comparing the precision of targets in
the non-targeted dataset to those detected by the targeted methods. Finally, the accuracy of the
online MS2-database “mzCloud” was evaluated using standards of 38 different metabolites. All
scripts utilized in data processing were programmed in the statistical software R[19] and com-
piled into a package called ‘metLab’ which is available at github[20].
Sample extraction
Extraction efficiency experiments revealed that CHCl3:MeOH (20:80) was the most effective
solvent for extraction of metabolites targeted in the present work. Brain sample extraction
(~100 mg) was initiated by adding tissue, 5 μL CHCl3:MeOH (20:80) per mg tissue and ZrO
beads (2.0 mm), into 1.5 ml polypropylene (PP) tubes. For the liver samples (~0.5-1g), 13 ml
PP tubes and 4.8 mm stainless steel beads were employed, using the same solvent to tissue
ratio as for brain samples. All samples were homogenized for 4 min at 1500 rpm, using a 1600
MiniG homogenizer (Spex Sample Prep, New Jersey, United States). Brain samples were cen-
trifuged using a Galaxy 14D microcentrifuge (VWR, Radnor, PA, USA) for 10 minutes at 8100
g while liver samples were centrifuged in a Eppendorf 5804 R (VWR) equipped with a F-34-6-
38 fixed-angle rotor (Eppendorf, VWR) for 10 minutes at 12900 g. Two dilutions per tissue,
1:5 and 1:100 for brain and 1:15 and 1:300 for liver, were carried out with pure MeOH before
addition of 120 μL of IS solution (>99% MeOH). Extraction of human plasma was carried out
by adding 500 μL of CHCl3:MeOH (20:80) and ZrO beads (2.0 mm) to PP-tubes containing
the 100 μL aliquots of sample. The samples were homogenized for 4 min (1500 rpm) and then
centrifuged (8100 g) for 10 minutes using a Galaxy 14D microcentrifuge (VWR, PA, USA).
Prior to analysis the samples were diluted 1:5 through addition of 120 μL of IS solution (>99%
MeOH) to 30 μL of NIST extract.
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QqQHILIC-analysis
Targeted analysis of amino acids, biogenic amines, nucleobases and neurotransmitters was
carried out using a Dionex UltiMate 3000+ coupled to a TSQ-Quantiva (Thermo Scientific,
Fig 1. Study workflow. An overview of the workflow adapted for the analytical method, the processing required post acquisition and the analysis and evaluation of the
collected data. Hydrophilic interaction chromatography (HILIC), Flow-Injection (FI), Signal Drift Correction (SDC).
https://doi.org/10.1371/journal.pone.0207082.g001
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Waltham, Massachusetts, United States) via a heated electrospray ionization (HESI) source.
Targets were chromatographed on an Acquity BEH-Amide hydrophilic interaction liquid
chromatography (HILIC) column (2.1 × 100 mm, 1.7 μm) equipped with a Vanguard pre-col-
umn (2.1 × 5 mm, 1.7 μm) from Waters (Milford, Massachusetts, United States). The mobile
phases consisted of (A) Milli-Q water with 0.1% FA and (B) ACN with 0.1% FA. The eluent
flow rate was maintained at 0.2 ml/min from 0–2.5 min, then increased to 0.5 ml/min from
2.5–2.8 min, at which point it was held constant until 9.5 min, then increased again to 0.8 ml/
min from 9.5–9.8 min where it was maintained until 10.8 min. The flow rate was then reduced
from 0.8–0.2 ml/min from 10.8–11.2 min where it was maintained until the end of the run
(11.3 min). During this time, the gradient of the mobile phase was ramped as follows: 0–2.8
min, 3% A; 2.8–6 min, 30% A; 6–8.5 min, 60% A; 8.5–9.5 min, 60% A; 9.5–11.3 min, 3% A.
The column was kept at 30˚C throughout the analysis while samples in the auto-sampler were
kept at 5˚C. Injection volume was 2 μL of extract and the washing program consisted of flush-
ing the needle with 50 μL of 90:10 (H2O:MeOH) before and after every injection. Source volt-
age was 5000V in positive ion mode and 4500V in negative ionization mode, sheath gas was 45
(arbitrary units), auxiliary gas was 20 (arbitrary units), sweep gas was 0.5 (arbitrary units),
source fragmentation was 20 V, CID gas pressure was 1.5 mTorr, while ion transfer tube and
vaporizer temperature both were set to 350˚C. The instrument was set to multiple reaction
monitoring (MRM) using the transitions and radio frequencies (RFs) listed in S1 Table and
the instrument parameters listed in S4 Table. Acquisition was carried out using XCalibur 3.1
(Thermo).
UPLC-MS/MS data were processed using XCalibur 3.0.63 (Thermo). For each target, a cali-
bration curve with at least 5 points was generated with concentrations ranging from 3.5 nM–
151.5 μM. Most metabolites were fit to linear calibration curves with 1/x2 weighting. The
exceptions were creatinine, malic acid and taurine, which were fitted to quadratic curves with
log-log weighting. The correlation coefficients for the calibration curves ranged between 0.946
and 0.999 (S2 Table). Detection limits were defined as the signal-to-noise ratio calculated by
XCalibur for the lowest calibration standards in which a peak was still measurable, divided by
itself and multiplied by three (S2 Table).
QqQFI analysis
Analysis of carnitines and lipids was carried out using a method adapted from Liebisch et al.
2005[21,22]. PEEK tubing (120 cm, 0.005” ID, 1/16” OD) was connected directly between the
UHPLC and the MS (i.e. a chromatography column was not used). The mobile phase consisted
of MeOH:CHCl3 (3:1) containing 10 mM ammonium acetate[21] which was maintained at
isocratic conditions throughout the run. The flow rate was ramped as follows: 0.0–0.4 min,
0.065 ml/min; 0.4–0.5 min, 0.065–0.030 ml/min; 0.5–1.5 min, 0.030 ml/min; 1.5–1.6 min,
0.030–0.090 ml/min; 1.6–5.0 min, 0.090 ml/min; 5.0–5.1 min, 0.090–0.50 ml/min; 5.1–5.7 min,
0.50 ml/min; 5.7–6.0 min, 0.50–0.065 ml/min. An exhaustive needle cleaning method was
required to prevent carry-over using this method. The procedure involved a 20 μL draw and
discharge of isopropanol, CHCl3 and MeOH (in that order) before sample injection. Samples
were maintained at 5˚C in the auto-sampler and the injection volume was 10 μL. Optimization
of the HESI-probe resulted in settings of 3600 V for source voltage (+HESI), 15 for sheath gas
(arbitrary units), 7 for auxiliary gas (arb), sweep gas 0 (arbitrary units), 25 V for source frag-
mentation, and 1.5 mTorr for CID gas. Ion transfer tube and vaporizer temperature were set
to 325˚C and 110˚C respectively. As with the QqQHILIC method, acquisition was carried out in
MRM-mode, using the transitions and RFs stated in the supplementary information (S1
Table) with XCalibur 3.1 (Thermo) and the instrument parameters listed in S4 Table.
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Peak integration was carried out using XCalibur 3.0.63. Automated peak integration using
XCalibur lead to a large proportion of lipids with either partially, or non-integrated peaks.
Consequently, the mouse macro-script software ‘Macro recorder’ (Jitbit LP, Edinburgh,
United Kingdom) was employed for semi-automated full chromatogram integration (Text A
in S1 Appendix). Peak areas were then subjected to isotopical deconvolution using the “fullDe-
con” function in our R-package, which is a version of the Liebisch et al. deconvolution method
[21]. The deconvoluted data was then exported to Excel (Microsoft, Redmond, Washington,
USA) for quantification, carried out according to Eq 1. ISs for individual lipids are stated in S2
Table. Background levels were negligible relative to the signal produced by the IS. Limit of
detection and quantification were determined as 10 times the concentration in the blanks run
with liver samples (S2 Table).
Areaanalyte
AreaIS
� ConcIS � Dilution factor ¼ Concanalyte ð1Þ
OrbiHILIC/C18+/- analysis
Non-targeted analysis was carried out using a Dionex Ultimate 3000+ coupled to a Q Exactive
HF Hybrid Quadropole-Orbitrap MS (Thermo Scientific, Waltham, Massachusetts, United
States). Two separate chromatographic methods were employed, in both positive and negative
mode, for a total of four analytical methods. The first method involved the same HILIC col-
umn and mobile phase as was used for the QqQHILIC analysis, with a slightly modified gradi-
ent. Initial conditions were 3% A / 97% B, which were maintained from 0–1.5 min, then
ramped to 25% A by 8 min, 40% A by 9.5 min, and 60% A by 11 min. By 13 min, the gradient
was returned to initial conditions (3% A), then equilibrated for a further 0.9 min prior to the
next injection. The flow was changed throughout the analysis as follows: 0–13 min, 0.3 ml/
min; 13–13.2 min, 0.3–0.6 ml/min; 13.2–13.7 min, 0.6 ml/min; 13.7–13.9 min, 0.6–0.3 ml/min.
The second method employed an Acquity UPLC HSS T3, C18 column (2.1 × 100mm, 1.8 μm)
equipped with a Vanguard pre-column (2.1 × 5 mm, 1.8 μm) from Waters (Milford, Massa-
chusetts, United States). The mobile phases were a modified version of the setup used by Hu
et al.[23]; A: Milli-Q + 10 mM ammonium formate (AF) and B: isopropanol:ACN (90:10) + 10
mM AF. The same mobile phases were used for both positive and negative analysis since weak
acids have been shown to be favorable for both types of ionization[24]. For both ionization
modes the following gradient was used: 0–1 min, A(98%), B(2%); 1–7 min, A(70%), B(30%);
7–15 min, A(2%), B(98%); 15–17 min, A(98%), B(2%); 17–19 min, A(98%), B(2%); 19–20 min,
A(98%), B(2%). The flow gradient was altered during analysis as follows: 0–16 min, 0.25 ml/
min; 16–16.1 min, 0.25–0.4 ml/min; 16.1–17.1 min, 0.4 ml/min; 17.1–17.2 min, 0.4–0.25 ml/
min; 17.2–19.0 min, 0.25 ml/min.
All samples were analyzed using both OrbiHILIC and OrbiC18 methods, in both positive and
negative modes, resulting in 4 analyses per sample. For each analysis, the Orbitrap was set to
full scan with data-dependent MS2 (Full MS!ddMS2), where the full scan (m/z 70–1000) had
a resolution of 120,000 and a maximum injection time (IT) of 200 ms. For every full scan,
three ddMS2-scans were carried out with a resolution of 15,000, a minimum AGC (automatic
gain control) target of 3.00×103 or 8.00×103 for OrbiHILIC or OrbiC18 analysis respectively, a
maximum IT of 30 ms and a stepped normalized collision energy (NCE) of 10, 20 and 35 (eV).
All data were acquired in profile mode using XCalibur 3.1.66.10. The ESI tune-file for positive
mode had the following settings: Source voltage 3700V, sheath gas 28 (arb), aux gas flow rate 7
(arb), sweep gas flow rate 1 (arb), S-lens RF level 55.0 and both the capillary and aux gas heater
temperatures set to 350˚C. The ESI tune-file for negative mode was the same as for positive
with the exception of sheath gas flow rate which was set to 25 (arb). The mass-calibration
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solutions used for positive and negative mode were the Pierce LTQ ESI Positive Calibration
Solution and Pierce LTQ ESI Negative Calibration Solution from Thermo (Waltham, Massa-
chusetts, United States). For mass-calibration of the instrument, we used a custom list which
included lower masses than the default calibration provided with the instrument (see S4 Table
for all information regarding instrumental settings of Orbitrap analysis). After positive and
negative calibration, the root mean squared mass accuracy was 0.15/0.21 ppm and 0.24/0.33
respectively.
Orbitrap data were processed using CD 2.0 (sequence correction) or 2.1 (all other data pro-
cessing) (Thermo-Fisher Scientific, USA). The full CD-workflow and settings are found in S1
Description. Criteria for putative identification were chosen as a combination of two different
properties; an mzCloud match score higher than 90% and the same identification being sug-
gested by at least one of either BioCyc, HMDB, Kyoto Encyclopedia of Genes and Genomes
(KEGG), LipidMaps, Pubchem or Small Molecule Pathway Database (SMPDB).
Signal drift correction
A variety of quality control (QC) samples were included to carry out and evaluate sequence
and inter-batch signal drift corrections. These included, a) technical replicate sequence QC
injections used for training the drift models (QCtrain) and b) extraction batch QCs used to test
the performance of the correction (QCtest). We tested four different methods to counteract sig-
nal drift and batch effects during non-targeted analysis. Three approaches used sequence and/
or extraction batch QCs: linear sequence correction[25], the batch MetaboAnalyst 3.0 correc-
tion feature[26] and batchCorr[27]. The fourth approach involved simply dividing metabolite
peak areas by the peak area of the IS (i.e. IS correction). Together, these four methods and
three combinations thereof (i.e. a total of seven different approaches) were evaluated for their
potential to reduce RSDs of selected metabolites in the NIST reference material. We also evalu-
ated the potential of each method to increase the number of features displaying RSDs of less
than 15 or 30% in QCtrain and QCtest.
Evaluation of method performance
Accuracy of the QqQHILIC method was assessed by comparing measured concentrations of 12
metabolites in NIST serum to certified concentrations and literature. For the QqQFI method
the accuracy was evaluated through comparisons with literature. Method within- and
between-batch precision as well as technical replicate precision were assessed using replicates
of serum and tissue samples analyzed within and between batches.
For the non-targeted workflow, three performance metrics were evaluated: 1) the potential
of the method to correctly identify metabolites, evaluated by comparison to substances mea-
sured in the targeted workflow; 2) precision of the non-targeted approach, as compared to tar-
geted analysis; and finally, 3) an evaluation of the number of features obtained by OrbiHILIC
versus OrbiC18 in both positive and negative modes. The first metric was assessed by counting
the number of compounds passing our putative identification filter (i.e mzCloud score >90%
+ exact mass library match). We also assessed the factors controlling the success of mass spec-
tral library matching using mzCloud by processing non-target data both with and without
inclusion of reference standards (i.e. the same standards used for QqQHILIC). The second met-
ric was evaluated by comparing RSDs for a subset of metabolites detectable by both the tar-
geted and non-targeted methods. In order to compare the precision of lipids measured via
QqQFI with those measured by OrbiC18+, a lipid search script was designed (part of our R-
package, see Text B in S1 Appendix for details) which flags lipids from the non-target dataset.
This script is necessary because the current version of CD does not offer a high throughput
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option for linking many MS2 fragments to their parent ions. Our newly developed script
obtains the retention time for a given lipid fragment (e.g. m/z 184 for PCs) and then matches
this to the parent ion at the same retention time. Finally, the third metric was evaluated
through comparison of the total number of features acquired from CD 2.1 processing of all
non-target data.
Results and discussion
Performance of targeted approach
A total of 90 of the 181 targeted metabolites (67 lipids / 23 non-lipids) were detectable in NIST
plasma. For targets measured by QqQHILIC, method accuracy ranged from 73–119% (n = 12
metabolites) when compared to reference values for NIST plasma[28] (Fig 2) while RSDs ran-
ged from 3.3 and 18.7%, (average 7.8%). This is particularly impressive considering the few
internal standards used in the method; albeit inclusion of additional internal standards may
improve accuracy and precision beyond that reported here. For lipids measured by QqQFI,
NIST reference values were unavailable. A comparison of lipid data for SRM 1950 revealed
that concentrations for up to 33 lipids measured in the present work were within 50–150% of
those reported by either Quehenberger et al. or Bowden et al. [29,30]. For the remaining lipids
measured in our study, concentrations were either outside this range or were not reported.
Thus lipid data reported here should be considered semi-quantitative. Notably, all lipids dis-
played excellent precision, ranging from 3.7–28.2% (mean 10.9%), which is comparable to the
precision of non-lipidic metabolites measured by HILIC. Considering the lack of chromatog-
raphy and few standards used in the QqQFI approach, the performance of the method is rea-
sonable. It is germane to note that some inconsistencies exist between previously published
data for lipid concentrations in SRM 1950. For example, Quehenberger et al. reported 16.2 μM
of SM(d18:0/C18:0) while Bowden et al. reported 2.0 μM [29,30]. Clearly, further work is nec-
essary to develop reliable reference concentrations for lipids in SRM 1950.
Fig 2. Accuracy of the QqQHILIC method evaluated through comparison with the NIST SRM 1950 certificate[28]. Error bars represent standard deviation for blue
bars but ‘expanded uncertainty’, as described in the NIST certificate for SRM 1950 for orange bars [28].
https://doi.org/10.1371/journal.pone.0207082.g002
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In fish tissues, 122 of 181 targets were detectable in liver (92 lipids and 30 non-lipids) and
130 of 181 targets (101 lipids and 29 non-lipids and) were detected in brain. Accuracy could
not be assessed in these tissues due to a lack of a certified reference material or ‘metabolite-
free’ tissue necessary for performing realistic spike/recovery experiments. Nevertheless, preci-
sion in both tissues (regardless of metabolite) was excellent, with average RSDs of 6.1 and 8.0%
for lipids and non-lipids in liver (n = 15), respectively, and 6.4 and 8.4% for lipids and non-lip-
ids in brain (n = 11) (S5 Table).
Performance of non-targeted approach
Peak-picking during non-target analysis required manual optimization and evaluation before
it was applied to the non-target dataset. Optimized parameters included dataset composition
(i.e. type of samples included in a batch processed by CD), signal intensity thresholds, reten-
tion time and mass windows. The optimized non-target workflows were then applied to each
dataset produced from a given tissue (i.e. analysis by C18 and HILIC columns in both ioniza-
tion modes) to investigate which chromatography/ionization combination detected the most
features. The results for each tissue are summarized in Fig 3 (Detailed breakdown in S6 Table).
Overall, analysis using +HESI resulted in 133–145% more features compared to–HESI (sum of
all features in both C18 and HILIC), highlighting the effectiveness of this ionization mode for
maximizing analyte coverage. HILIC produced 104–236% more features than C18 based on
the sum of all features in positive and negative mode in the same tissue. Therefore, in the
absence of a priori hypotheses necessitating a particular ionization approach/chromatographic
method (e.g. interest in fatty acids could prompt the use of C18 in negative mode), a +HESI/
HILIC analysis is expected to produce the largest number of chromatographic features.
The results from the mzCloud identification performance tests are provided in Fig 4 (See
S1 Dataset for details). For all tissues, the datasets processed together with reference standards
Fig 3. The impact of chromatography and ionization on the number of features obtained from the same samples run through four different combinations of
chromatography and ionization (C18(+), C18(-), HILIC(+) and HILIC(-)). Portrayed here as the percentage of each different combination of the total summed
amount of features detected in the same sample type and the number of features within parentheses (S6 Table).
https://doi.org/10.1371/journal.pone.0207082.g003
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had a higher number of features living up to our mzCloud matching criteria. In brain, 85 fea-
tures were identified when reference standards were included in data processing, while only 58
were identified when standards were not included. A similar finding was made in liver (i.e. 83
identified when processed with standards versus 66 without) as well as in the NIST material
(68 identified with standards versus 46 without).
In mzCloud, the similarity between a substance’s library MS2-spectrum and the single best-
quality MS2-spectrum in the experimental dataset determines its mzCloud score. In assigning
this score, mzCloud assumes that the best-quality MS2-spectrum acquired from one sample is
representative of the MS2-spectra for all other samples, thereby relying on retention time and
exact mass of the parent ion to ensure the substance is the same across all samples. This can be
problematic if the substance producing the best-quality MS2-spectrum is not the same as in
the other samples (e.g. in the case of isomers). The problem may be exacerbated when includ-
ing standards in the data processing workflow, since the MS2-spectrum of the standard will
undoubtedly be selected over that of samples. In the present work, the number of features pass-
ing our putative identification filter increased by an average of 40% in all three tissues when
reference standards were included and we confirmed that there were no instances of misiden-
tification. Nevertheless, caution is warranted when interpreting mzCloud scores in suspect-
confirmation analysis if reference standards and samples are processed in the same CD analy-
sis. Judging by these results, a compound living up to the criteria of our filter in a dataset com-
prised solely of samples is most likely to be assigned level 2 putative identification[31]. This
means that when faced with the decision whether to invest resources into confirming the iden-
tity of a compound of interest, passing the filter is a strong indicator of that this is plausibly
worthwhile.
Fig 4. Number of compounds living up to our mzCloud filter-criteria in NIST (left), brain (center) and liver (right). Compounds are grouped based on how many
compounds were detected through CD analysis with (green) or without reference standards (red). Any compounds which were only detected in the reference standards
were removed from these graphs.
https://doi.org/10.1371/journal.pone.0207082.g004
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Signal drift modelling and correction of non-target workflow
The performance of each of the 4 sequence correction methods, and combinations thereof, is
summarized in Fig 5 (S2 Dataset for details). As shown in Fig 5, batchCorr outperformed the
other signal drift correction methods in all comparisons except for in QCtest where linear
sequence correction outperformed it in liver tissue. This is impressive considering that no
adjustment to the run-order or QC-frequency requirements were made prior to analysis (i.e.
batchCorr specifies injection of QCtrain every 5th injection[29], while the present work used
every 10th injection). Thus, batchCorr likely underperformed in this particular analysis despite
having outperformed the other sequence correction cases in almost all cases. Therefore, batch-
Corr was applied to all non-targeted data as part of the data processing prior to comparison to
the targeted data.
Fig 5. Comparison of different signal drift correction techniques in QCtest & QCtrain. a) Comparison in terms of how many features that were below 30%
RSD in QCtrain. The acronyms used for the different signal drift methods are as follows: “No corr.” = No correction; “Lin.” = Linear sequence correction;
“Metab.” = Metaboanalyst batch correction; “IS” = Internal standard correction; “batchCorr” = batchCorr. b) Number of compounds in brain and liver QCtest,
below 30% and 15% RSD post correction.
https://doi.org/10.1371/journal.pone.0207082.g005
Comparison of targeted and non-targeted metabolomics
PLOS ONE | https://doi.org/10.1371/journal.pone.0207082 November 15, 2018 12 / 18
Comparison of targeted versus non-targeted approaches
While triple-quadrupole instruments are often perceived as the gold standard for targeted
metabolomics[3,6,17], this platform is not infallible and requires close scrutiny. In the present
work, the application of OrbiHILIC was used to identify two instances of false positives (seroto-
nin and DOPA) in data generated through QqQHILIC. In both cases, a closer inspection of
HRMS data revealed features within ±0.5 Da of DOPA and serotonin, and with MS2 fragments
consistent to those used for targeted analysis. However, when a narrower mass range was
applied, these substances were not observable in samples. For the remaining targets, peaks
observed in the QqQHILIC analysis were consistent with the OrbiHILIC dataset.
Analysis of the NIST material revealed 16 compounds comparable between QqQHILIC and
OrbiHILIC while the R-script filtered out 45 lipids from the OrbiC18+ method which were com-
parable to the QqQFI method. All of the non-lipid analytes had better RSDs in the targeted
dataset versus the non-targeted (signal drift-corrected) dataset, as seen in Fig 6 (S3 Dataset).
For the lipids, 44/45 of the analytes had better RSDs when analyzed using QqQFI (8.7% RSD)
as compared to OrbiC18+ (92.1% RSD; S4 Dataset).
Analysis of liver revealed 21 targets measured by both QqQHILIC and OrbiHILIC+. For 19 of
21 substances, precision was higher when using QqQHILIC (mean 6.9% RSD) versus OrbiHILIC+
(mean 17.1% RSD) for technical replicates while for between-batch samples all 21 were superior
in QqQHILIC (means RSDs of 4.7% and 70.8%, respectively; S3 Dataset). In total 36 lipids were
comparable between QqQFI and OrbiC18+. Precision for these lipids was better for 34 of them in
QqQFI versus OrbiC18+ considering technical replicates (mean 3.9% vs 30.2% RSD) and 35
when considering between-batch samples (mean 6.8% vs 33.3% RSD)(S4 Dataset).
Finally, analysis of brain tissue revealed 103 comparable substances (between QqQ and
Orbitrap). Of the 22 non-lipids detectable by both platforms, 17 compounds had higher preci-
sion in QqQHILIC vs OrbiHILIC+ when considering technical replicates (mean 6.8% vs 19.9%
RSD) while only 12 were better when considering between-batch samples (mean 11.9% vs
26.6% RSD; S3 Dataset). In technical replicates, 77 lipids had lower RSDs in QqQFI vs OrbiC18+
(mean RSDs of 7.0% vs 31.8%, respectively). For between-batch samples 77 lipids had higher
precision in QqQFI vs OrbiC18+ which is also reflected in the lower average RSD of QqQFI com-
pared to OrbiC18+ (mean 7.4% vs 36.4%, respectively) (S4 Dataset).
Overall, this comparison revealed that both targeted approaches (i.e. QqQHILIC and QqQFI
analysis), have an overall higher precision than Orbitrap-analysis when configured as in this
study. This difference is likely to stem from inherent challenges with data acquisition and pro-
cessing of Orbitrap data, rather than technical superiority of QqQ methods. For example, the
current version of CD (software used for processing Orbitrap data) does not include options
to control or optimize peak integration, resulting in variable quality in peak integration. See
Figure A and B in S1 Description. As Orbitrap data processing software improves, an improve-
ment in the precision of non-target data can be expected. Nevertheless, at this point in time,
our data indicate that a targeted methodology is more likely to detect a statistically significant
perturbation due to substantially lower RSDs, provided the metabolites of interest are known.
Conclusions
In this study we developed stand-alone targeted and non-targeted metabolomics approaches
and then evaluated their respective performance through comparison to each other. Among
the important findings of this study were that: (i) Targeted analysis has an overall better preci-
sion than non-targeted analysis (even after sequence signal drift correction). This is most prob-
ably due to non-optimal peak picking and integration in CD and will likely improve as the
methodology behind processing Orbitrap data develops. (ii) Signal correction comparisons are
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non-trivial and in some cases yielded dichotomous results; nevertheless, for the purposes of
retaining the most number of features, batchCorr outperforms other correction algorithms in
most instances. (iii) Although mzCloud shows considerable promise as a tool for peak identifi-
cation, it still has a long way to go before it will be able to positively identify a large proportion
of the total number of peaks detected. However, anything above a 90% mzCloud hit is very
likely to be a correct level 2 putative identification and can be used to guide a decision on
whether to go forward with a level 1 identification or not. (iv) When faced with limited
resources and/or sample size and in the absence of prior knowledge on the metabolites of
interest, HILIC chromatography combined with positive ionization is the preferred approach
for non-targeted metabolomics due to the number of generated peaks.
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